TCIRG1
V-type proton ATPase 116 kDa subunit a 3
Also known as: a3, Atp6i, ATP6N1C, ATP6V0A3, OC-116, OC116, TIRC7, VPP3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13488
- Gene
- TCIRG1
- Ensembl
- ENSG00000110719
- Chromosome
- 11
- Canonical length
- 830 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a subunit of a large protein complex known as a vacuolar H+-ATPase (V-ATPase). The protein complex acts as a pump to move protons across the membrane. This movement of protons helps regulate the pH of cells and their surrounding environment. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, and receptor-mediated endocytosis. V-ATPase is comprised of a cytosolic V1 domain and a transmembrane V0 domain. Alternative splicing results in multiple transcript variants. Mutations in this gene are associated with infantile malignant osteopetrosis. [provided by RefSeq, May 2017]
Canonical amino-acid sequenceUniProt
830 residues, UniProt reviewed canonical sequence.
>Q13488|TCIRG1
1 MGSMFRSEEV ALVQLFLPTA AAYTCVSRLG ELGLVEFRDL NASVSAFQRR FVVDVRRCEE
61 LEKTFTFLQE EVRRAGLVLP PPKGRLPAPP PRDLLRIQEE TERLAQELRD VRGNQQALRA
121 QLHQLQLHAA VLRQGHEPQL AAAHTDGASE RTPLLQAPGG PHQDLRVNFV AGAVEPHKAP
181 ALERLLWRAC RGFLIASFRE LEQPLEHPVT GEPATWMTFL ISYWGEQIGQ KIRKITDCFH
241 CHVFPFLQQE EARLGALQQL QQQSQELQEV LGETERFLSQ VLGRVLQLLP PGQVQVHKMK
301 AVYLALNQCS VSTTHKCLIA EAWCSVRDLP ALQEALRDSS MEEGVSAVAH RIPCRDMPPT
361 LIRTNRFTAS FQGIVDAYGV GRYQEVNPAP YTIITFPFLF AVMFGDVGHG LLMFLFALAM
421 VLAENRPAVK AAQNEIWQTF FRGRYLLLLM GLFSIYTGFI YNECFSRATS IFPSGWSVAA
481 MANQSGWSDA FLAQHTMLTL DPNVTGVFLG PYPFGIDPIW SLAANHLSFL NSFKMKMSVI
541 LGVVHMAFGV VLGVFNHVHF GQRHRLLLET LPELTFLLGL FGYLVFLVIY KWLCVWAARA
601 ASAPSILIHF INMFLFSHSP SNRLLYPRQE VVQATLVVLA LAMVPILLLG TPLHLLHRHR
661 RRLRRRPADR QEENKAGLLD LPDASVNGWS SDEEKAGGLD DEEEAELVPS EVLMHQAIHT
721 IEFCLGCVSN TASYLRLWAL SLAHAQLSEV LWAMVMRIGL GLGREVGVAA VVLVPIFAAF
781 AVMTVAILLV MEGLSAFLHA LRLHWVEFQN KFYSGTGYKL SPFTFAATDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TCIRG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 278 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 278 nTPM
- spleen: 186 nTPM
- lung: 111 nTPM
- adrenal gland: 104 nTPM
- bone marrow: 85 nTPM
- small intestine: 82 nTPM
Single-cell type
- neutrophils: 169 nCPM
- monocytes: 135 nCPM
- foveolar cells: 117 nCPM
- kupffer cells: 114 nCPM
- pancreatic acinar cells: 81 nCPM
- extravillous trophoblasts: 77 nCPM
Immune cell
- neutrophil: 151 nTPM
- non-classical monocyte: 146 nTPM
- intermediate monocyte: 110 nTPM
- eosinophil: 74 nTPM
- classical monocyte: 66 nTPM
- myeloid DC: 49 nTPM
Brain region
- thalamus: 32 nTPM
- cerebral cortex: 24 nTPM
- pons: 19 nTPM
- choroid plexus: 17 nTPM
- medulla oblongata: 17 nTPM
- white matter: 16 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TCIRG1.
Disease | AllUniProt
Conditions TCIRG1 is implicated in, by any mechanism.
- Osteopetrosis, autosomal recessive 1 (OPTB1) MIM:259700
Disease | GeneticClinVar
279 pathogenic / likely-pathogenic of 1,784 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive osteopetrosis 1
- Osteopetrosis
- TCIRG1-related disorder
- Autosomal recessive osteopetrosis
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.87
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.63
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- autophagosome assembly
- B cell differentiation
- bone resorption
- cellular defense response
- cellular response to cytokine stimulus
- enamel mineralization
- establishment of cell polarity
- establishment of vesicle localization
- gene expression
- hematopoietic stem cell homeostasis
- immunoglobulin mediated immune response
- inflammatory response
- intracellular calcium ion homeostasis
- lysosomal lumen acidification
- macroautophagy
- memory T cell activation
- optic nerve development
- ossification
- osteoclast differentiation
- osteoclast proliferation
- pH reduction
- phagosome acidification
- positive regulation of cell population proliferation
- protein catabolic process in the vacuole
- proton transmembrane transport
- regulation of gene expression
- regulation of insulin secretion
- regulation of osteoblast differentiation
- regulation of proton transport
- retina development in camera-type eye
- ruffle organization
- T cell differentiation
- T cell homeostasis
- T-helper 1 cell activation
- tooth eruption
- vacuolar acidification
- dentin mineralization
- response to silver ion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TCIRG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TCIRG1 as an antibody target. Whether an autoantibody or antibody against TCIRG1 could matter depends on whether native TCIRG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TCIRG1 is annotated at the cell surface, where native TCIRG1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TCIRG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...